PV EAEU 1969
Way back in the former USSR, the Department of registration, systematization and expedited reporting of drug side effects pioneered drug efficacy and safety monitoring.
Biomapas is established and conducts its first BE studies
Phase I-IV Clinical Trials are initiated
First studies performed in the CIS region.
First PK/PD Studies with Biologicals/Biosimilars.
The Pharmacovigilance department is established.
The Regulatory Affairs department is established.
Biomapas adds Medical Devices services to its portfolio and completes first projects.
Biomapas completes the ISO 9001:2008 to ensure high-quality services for its clients.
The launch of Clinical Safety and Medical Monitoring services
New offices open up in Russia and Georgia.
New office opens up in Switzerland.
New office opens up in Ukraine.
Integrated ISO 9001:2015 and ISO 13485:2016
New office opens up in Sweden.
New office opens up in Poland.
New office opens up in Kazakhstan.
Biomapas adds Medical Information to its portfolio and consolidates its position as a partner from Early development to Post-Marketing.
World Drug Safety Congress Europe
Let’s meet at the World Drug Safety Congress Europe 2023, an exciting drug safety safety event in Amsterdam, Netherlands.
Meet us at the international partnering event to discuss the key challenges in clinical development in December in Stockholm.